| VIAV | Viavi Solutions (VIAV) shares rose 4.9% today following the launch of its new cybersecurity product, Observer Threat Forensics. The offering, designed for retrospective investigation across various telemetry types, emphasizes enterprise security visibility and incident response. The company plans live demonstrations at the upcoming RSA Conference 2026, which is contributing to investor attention. | Bullish | 2026-03-19 22:23:01 |
| NATH | Nathan's Famous Inc. (ISIN: US6311001050) is showing resilience in a volatile consumer market, attracting European investor interest due to its strong franchise growth and upcoming summer demand. The company's asset-light franchise model, characterized by high margins and steady royalty inflows, positions it as a defensive play in the restaurant sector, offering a unique investment opportunity with stable cash flows and dividends. Despite potential risks like over-reliance on a single product and geopolitical factors, the outlook points to mid-single-digit royalty growth and a consistent dividend track record. | Bullish | 2026-03-19 22:23:01 |
| RDNT | Alma Gregory Sorensen, an insider at RadNet, Inc. (NASDAQ: RDNT), reported recent and proposed transactions via a Form 144 filing. The disclosure details sales of 15,000 shares for over $932,000 and 5,919 shares for over $365,000 on March 18 and March 16, 2026, respectively. The filing also includes entries for restricted stock vesting on earlier dates. | Bearish | 2026-03-19 22:23:01 |
| AME | AMETEK's Executive VP and CFO, Dalip Puri, received equity compensation including 11,960 stock options with an exercise price of $212.77 per share and 3,780 shares of common stock. After tax withholdings, Puri now directly holds 11,832 shares of common stock. These awards are part of the company's 2020 Omnibus Incentive Compensation Plan and align executive incentives with company performance. | Bearish | 2026-03-19 22:23:01 |
| RIG | Transocean (RIG) shares climbed 3.36% amidst increasing global demand, despite a Q4 earnings miss. The company is pursuing a merger with Valaris to strengthen its position in offshore drilling, while also securing new contracts worth $610 million in Brazil and Australia, boosting its contracted backlog. While Susquehanna raised its price target for RIG, Barclays downgraded its stock rating due to current valuation caps, highlighting a mixed market reaction to Transocean's strategic moves and financial performance. | Bullish | 2026-03-19 22:23:01 |
| RLAY | Perceptive Life Sciences Master Fund, Perceptive Advisors LLC, and Joseph Edelman have disclosed a 5.3% beneficial ownership stake in Relay Therapeutics (RLAY), totaling 9,404,725 shares of Common Stock. This ownership represents shared voting and dispositive power among the entities. The percentage calculation is based on 178,725,809 shares outstanding as of February 20, 2026, as reported in Relay Therapeutics' Form 10-K. | Bearish | 2026-03-19 22:23:01 |
| TMUS | T-Mobile US has announced that it will maintain its quarterly dividend at $1.02 per share. The dividend is scheduled to be paid on June 11 to shareholders who are on record as of May 29, 2026. This announcement confirms the consistency of T-Mobile's dividend payout for the upcoming quarter. | Bearish | 2026-03-19 22:23:01 |
| RGR | Beretta Holding S.A., holding 9.95% ownership of Sturm, Ruger & Company, has launched a proxy campaign to elect four director nominees to Ruger's board. The company cites sustained share price underperformance, rapid operational deterioration, and a lack of alignment from the current board as reasons for the urgent need for change. Beretta Holding is urging shareholders to support its nominees to restore value and improve oversight at Ruger. | Bearish | 2026-03-19 22:23:01 |
| PGNY | Progyny, Inc.'s Chief Product Officer, Geoffrey Clapp, reported a tax-related disposition of 3,275 common shares on March 17, 2026. These shares, valued at $17.42 each, were withheld to cover taxes upon the vesting of restricted stock units. Following this event, Clapp directly holds 60,647 shares of Progyny common stock. | Bearish | 2026-03-19 22:23:01 |
| REVB | Revelation Biosciences (NASDAQ:REVB) stockholders have approved the issuance of common stock related to Class J Common Stock Warrants, overriding the Nasdaq 20% issuance cap. This approval extends the warrants' expiration to March 18, 2031, allowing the company to proceed with their exercise. The company also recently announced a 1-for-4 reverse stock split, an agreement for warrant exercise for up to 13,065,000 shares, and progress with the FDA for its Gemini treatment for Acute Kidney Injury. | Bearish | 2026-03-19 22:23:01 |
| RGR | Stephen J. Timm has been appointed to the board of Sturm Ruger & Co Inc (RGR) and has filed a Form 3, an initial statement of beneficial ownership. This filing confirms his status as a director but indicates no reported stock transactions or holdings in the provided summary fields. The Form 3 clarifies that he is not a ten percent owner and no derivative securities are reported. | Bearish | 2026-03-19 22:23:01 |
| AME | AMETEK executive Thomas C. Marecic, President – Electronic Instruments, received new equity awards comprising stock options on 3,930 shares at an exercise price of $212.77 and 1,240 restricted shares. To cover taxes, 253 shares were withheld, which is treated as a disposition but not an open-market sale. Following these transactions, Marecic directly owns 45,533 shares, with additional holdings in a 401(k) plan and through his wife. | Bearish | 2026-03-19 22:23:01 |
| RBA | This article reports an SEC filing by RB Global Inc. (RBA) of Form ARS. The filing was made on March 19, 2026, at 05:15 PM and is categorized as having a low impact and neutral sentiment. The article provides details of the filing, along with recent news and other SEC filings related to RB Global Inc. | Bearish | 2026-03-19 22:23:01 |
| ADM | Archer-Daniels-Midland (ADM) has been recognized as one of the World’s Most Ethical Companies and has committed US$500,000 to support farmer resilience through American Farmland Trust. These actions, alongside a recent SEC settlement and DOJ investigation closure, aim to strengthen ADM's ethical and sustainable profile. While these efforts bolster ADM's investment narrative around resilience, investors are still focused on biofuel policy clarity and potential margin pressures in its core Ag Services & Oilseeds segment. | Bearish | 2026-03-19 22:23:01 |
| OKE | ONEOK (OKE) recently reported a fourth-quarter revenue shortfall and a cautious 2026 outlook, leading to analyst downgrades, despite a higher dividend and reduced long-term debt. The stock is currently trading near its analyst price target of $87.30, indicating it is slightly undervalued, with future performance dependent on execution and capital allocation. The article emphasizes reviewing the complete narrative and associated risks to make an informed investment decision. | Bearish | 2026-03-19 22:23:01 |
| PRDO | Perdoceo Education (PRDO) has shown strong share price momentum and positive analyst sentiment, partly due to solid quarterly revenue growth and a constructive 2026 outlook. The company is considered undervalued by 18.4%, with a fair value of $42 per share, driven by expectations of continued expansion in high-demand programs and flexible learning options. However, this valuation relies on enrollment and margin assumptions, and potential regulatory or funding shifts could challenge the outlook. | Bullish | 2026-03-19 22:23:01 |
| EBAY | Mexico's culture ministry has requested eBay remove listings for 195 pre-Hispanic archaeological objects and return them to Mexico, arguing their sale is illegal and they are part of Mexico's cultural heritage. The US-based seller claims the items were legally acquired with provenance, stating that international treaties are not retroactive. eBay states it does not allow illegal sales and is investigating the flagged listings. | Bearish | 2026-03-19 22:23:01 |
| RDW | Redwire (NYSE:RDW) Director Ae Red Holdings, LLC recently sold 81,319 shares of the company's stock for approximately $814,000, bringing their total ownership down by 0.19%. This sale is part of several insider transactions, including multi-million-share disposals in late January and early February, although Ae Red Holdings, LLC still retains a significant stake of over 43 million shares. Despite missing EPS estimates, Redwire's revenue exceeded expectations, and analysts maintain a "Moderate Buy" rating with a consensus price target of $13.89. | Bearish | 2026-03-19 22:23:01 |
| PLXS | Plexus (NASDAQ:PLXS) CEO Todd Kelsey sold 1,500 shares of the company's stock on March 18th at an average price of $194.24, totaling $291,360. This transaction reduced his ownership by 1.8% to 81,791 shares. The company recently reported strong Q1 results, with EPS of $1.78 beating estimates and revenue up 9.6% year-over-year, and has a "Moderate Buy" consensus rating from analysts. | Bearish | 2026-03-19 22:23:01 |
| MSCI | MSCI CFO Andrew Wiechmann sold 450 shares of the company's stock for $252,000 on March 17th, decreasing his stake by 1.96%. The sale followed MSCI's strong Q4 earnings, where the company beat analyst estimates with EPS of $4.66 and revenue of $822.5 million, leading to a raised quarterly dividend. Analysts currently have a "Moderate Buy" rating on MSCI with an average price target of $674. | Bearish | 2026-03-19 22:23:01 |
| INCY | Incyte insider Pablo Cagnoni sold 18,667 shares of the company's stock for approximately $1.76 million, reducing his stake by 7.36%. The transaction occurred on March 17th, with shares sold at an average price of $94.24. Despite the insider sale, institutions like Vanguard, AQR, and Invesco have increased their positions in Incyte, which has a consensus "Hold" rating and an average target price of $103.44. | Bearish | 2026-03-19 22:23:01 |
| TECH | Bio-Techne Corp. shares rose 1.54% on Thursday, closing at $51.59, despite a general market downturn with the S&P 500 and Dow Jones Industrial Average both falling. The company's stock is currently 28.51% below its 52-week high of $72.16 achieved in January. This performance indicates a stronger showing compared to the broader market and its competitors. | Bullish | 2026-03-19 22:23:01 |
| AME | AMETEK, Inc.'s CEO, David A. Zapico, reported equity compensation including stock options for 47,230 shares and 11,930 restricted shares. Some shares were withheld for tax obligations, a routine adjustment for compensation-related awards, not open-market transactions. This activity reflects standard long-term incentive compensation for the CEO. | Bearish | 2026-03-19 22:23:01 |
| RKLB | Rocket Lab's stock (NASDAQ:RKLB) surged 3.5% after securing a significant $190 million Department of War contract, bringing its backlog to over $2 billion. Analysts have raised price targets, with a consensus of $75.92, reflecting confidence from recent wins and a $1 billion "war chest" for production scaling, despite some dilution concerns from a potential equity offering. Insider sales have occurred, yet institutional investors continue to adjust their positions. | Bullish | 2026-03-19 22:23:01 |
| LYV | Live Nation CEO Michael Rapino defended his company against accusations of monopolistic practices in an antitrust trial. He countered claims that Live Nation uses anti-competitive tactics to dominate the live entertainment industry, emphasizing the company's vertically integrated business model and its efforts to create a successful framework for artists and itself. The trial, initially brought by the Justice Department, is now being pursued by a coalition of states dissatisfied with a recent settlement. | Bearish | 2026-03-19 22:23:01 |
| CVS | John E. Gallina has been named a reporting director for CVS Health (CVS), as indicated by a recent Form 3 filing with the SEC. This filing serves as an initial statement of beneficial ownership, registering Gallina as an insider without detailing any stock transactions or holdings at this time. The Form 3 confirms his role as a director, subjecting him to future reporting obligations for company securities. | Bearish | 2026-03-19 22:23:01 |
| TJX | TJX Companies (NYSE:TJX) saw its stock price rise 1.2% on Thursday, closing at $154.6950, with trading volume down 28% from average. Despite CEO Ernie Herrman selling 30,000 shares, analysts largely maintain a "Buy" rating with an average target price of $167.55, reflecting institutional ownership of over 91%. The company recently beat Q4 earnings estimates and provided strong FY2027 guidance. | Bullish | 2026-03-19 22:23:01 |
| UNH | UnitedHealth Group (NYSE:UNH) shares dropped 1.4% during mid-day trading to $280.35, with trading volume significantly lower than average. Despite the dip, the company reported strong Q4 earnings, surpassing analyst estimates for EPS and revenue, and declared a quarterly dividend of $2.21. Analyst ratings are mixed, with a consensus of "Moderate Buy" and an average price target of $372.13. | Bearish | 2026-03-19 22:23:01 |
| RUSHA | Rush Enterprises announced the resignation of Jason Wilder as Chief Operating Officer, who is leaving to pursue other opportunities, a decision not related to disagreements with the company. Michael J. McRoberts, former COO and current Senior Advisor, will provide interim support for COO duties during the transition period. The company also released a new Investor Presentation for upcoming meetings with investors and analysts, accessible on its Investor Relations website. | Bearish | 2026-03-19 22:23:01 |
| LNT | Alliant Energy (NASDAQ: LNT) has initiated a new equity distribution agreement, allowing it to sell up to $1 billion in common stock through at-the-market offerings and forward sale arrangements. The proceeds are intended for general corporate purposes, including debt repayment, working capital, and capital expenditures. This program provides the company with flexibility in financing its investments as a regulated utility. | Bearish | 2026-03-19 22:23:01 |
| PNFP-P-C | Pinnacle Financial (PNFP) is being added to the KBW Nasdaq Bank Index, signifying its strong growth and strong performance in the financial sector. The company, operating through Pinnacle Bank, boasts consistent revenue growth, efficient operations, and an attractive valuation with its P/E ratio near a 2-year low. Despite some inherent sector risks, its robust financial health, confirmed by a high Piotroski F-Score and positive insider buying trends, indicates a promising outlook. | Bearish | 2026-03-19 22:23:01 |
| GEHC | GE HealthCare Technologies Inc.'s President and CEO, Peter J. Arduini, is estimated to receive $18,562,794 in compensation for 2025, a 4.98% decrease from 2024. This estimate is based on a recent SEC DEF14A filing. The article also details recent hedge fund activity, with 541 institutional investors adding shares and 687 decreasing positions, and analyst ratings which are predominantly "Buy" or "Overweight" with a median price target of $92.0 from 11 analysts. | Bearish | 2026-03-19 22:23:01 |
| BSX | Boston Scientific Corp's CEO, Michael F. Mahoney, is estimated to have received $23,532,050 in compensation for 2025, an 8.97% increase from 2024, based on a recent SEC filing. The article also details insider trading activity, with multiple executives selling shares, and lists government contracts awarded to BSX. Additionally, it provides information on congressional stock trading involving BSX, hedge fund activity, analyst ratings, and price targets. | Bearish | 2026-03-19 22:23:01 |
| TROW | Jessica Sclafani has been named the new head of T. Rowe Price Group Inc.’s retirement strategist team, succeeding Michael Davis, who is retiring on May 1. Sclafani joined T. Rowe Price in 2022 and will lead the expanded global retirement team leadership, which also includes Richard Parkin for U.K. retirement and Scott Keller for Americas, APAC, and EMEA distribution. Davis, who joined in 2016 and led the global retirement strategy team, is celebrated for his significant contributions to the firm's retirement business. | Bullish | 2026-03-19 22:23:01 |
| HBAN | Huntington National Bank is a regional bank, established in 1866 and headquartered in Columbus, OH, operating primarily in 14 U.S. states with 1,000 branches and over 1,600 ATMs. The bank offers a variety of checking, savings, credit card, and loan products, many with fee waiver opportunities and benefits like early direct deposit and overdraft flexibility. Huntington is also recognized for its leadership in climate responsibility and community involvement, having received awards for promoting homeownership and being acknowledged by Bank.Green. | Bullish | 2026-03-19 22:23:01 |
| ZBAO | Zhibao Technology Inc.'s CEO and director, Ma Botao, has filed an initial statement of beneficial ownership (Form 3) disclosing an indirect stake of 16,816,692 Class B ordinary shares. These shares are held through various entities including Mavy Holdings Limited, Shenbao Limited Partnership, Shanghai Xinhui Investment Consulting Co., Ltd., and Maximum Global Holdings Limited. Ma Botao is considered a major shareholder, with voting and dispositive power over these holdings. | Bearish | 2026-03-19 22:23:01 |
| AXGN | Axogen's Chief Innovation Officer, Erick Wayne DeVinney, sold 5,221 shares of common stock for approximately $171,457 and disposed of 2,870 shares to cover tax obligations. Despite the stock's recent retreat, analysts maintain a bullish outlook with price targets between $39 and $43. The company also recently surpassed Q4 2025 earnings and revenue expectations. | Bearish | 2026-03-19 22:23:01 |
| QURE | Kessler Topaz Meltzer & Check, LLP has filed a securities fraud class action lawsuit against uniQure N.V. (NASDAQ: QURE) on behalf of investors who purchased ordinary shares between September 24, 2025, and October 31, 2025. The lawsuit alleges that uniQure made material misstatements regarding its Huntington's disease gene therapy drug, AMT-130, and its Biologics License Application (BLA) timeline. Investors have until April 13, 2026, to seek lead plaintiff status. | Bearish | 2026-03-19 22:23:01 |
| AME | AMETEK's Chief Commercial Officer, Emanuela Speranza, was granted stock options for 1,790 shares and 570 restricted stock units (RSUs), both vesting in three equal annual installments starting March 18, 2027. She also exercised 296 previously granted RSUs into common shares, with 134 shares withheld to cover taxes. Following these transactions, Speranza directly holds 30,201 common shares, 1,790 stock options, and 594 RSUs. | Bearish | 2026-03-19 22:23:01 |
| AMAT | Applied Materials, Inc. (AMAT) is under investor scrutiny due to institutional stake reductions and a strong Q1 2026 earnings beat. The article highlights the tension between AI-driven growth and high valuations in the semiconductor equipment sector. Despite robust earnings and crucial roles in next-gen tech, concerns persist regarding valuation, semiconductor cyclicality, and geopolitical risks, making it a nuanced investment for DACH portfolios. | Bearish | 2026-03-19 22:23:01 |
| LYV | Live Nation CEO Michael Rapino faced intense questioning at an antitrust trial regarding Ticketmaster fees and "outrageous" concert add-ons. States are suing Live Nation, alleging an unlawful monopoly that leads to inflated prices and anti-competitive practices. Testimony revealed Rapino acknowledged high fees in 2016 and defended a controversial $15 chair rental fee, while denying accusations of pressuring venues or being aware of rising service fees. | Bearish | 2026-03-19 22:23:01 |
| FDX | FedEx reported strong fiscal third-quarter earnings, exceeding analyst expectations, and subsequently raised its full-year guidance for revenue and adjusted EPS. The company's stock price jumped significantly in aftermarket trading, reflecting investor confidence in its Network 2.0 integration and cost-saving initiatives. FedEx plans to continue closing parcel terminals and projects over $1 billion in transformation-related savings for FY26. | Bearish | 2026-03-19 22:23:01 |
| GM | This article details the latest weekly vehicle recalls from several major manufacturers, including Audi, Ford, General Motors, Kia, Jeep, and Volvo. The recalls address various safety concerns such as lane departure system errors, headlight malfunctions, potential loss of drive power, electronic owner's manual download issues, liftgate cover detachment, seat belt buckle problems, and seat belt warning system failures. Owners are provided with remedy information, notification dates, and customer service contacts for each specific recall. | Bearish | 2026-03-19 22:23:01 |
| REYN | Reynolds Consumer Products (NASDAQ:REYN) Director Rolf Stangl recently purchased 4,705 shares of the company's stock, increasing his direct ownership by 13.51%. The shares were acquired at an average price of $21.06 per share, totaling approximately $99,087. This insider buying activity comes as the company trades near its 52-week lows, with a current dividend yield of 4.4% and analysts maintaining a "Hold" rating with a consensus price target of $25.43. | Bearish | 2026-03-19 22:23:01 |
| PLD | Prologis has partnered with Singapore's sovereign wealth fund GIC in a $1.6 billion joint venture to develop and acquire 4.1 million square feet of build-to-suit logistics facilities across the U.S. This collaboration signals a potential rebound in the U.S. industrial property market, with a focus on mitigating risk by developing properties for specific tenants like Amazon. The venture aims to capitalize on strong customer conviction for made-to-order logistics spaces as speculative construction slows due to market conditions. | Bullish | 2026-03-19 22:23:01 |
| NIO | Nio's cumulative in-house chip production has surpassed 550,000 units, significantly driven by their Yangjian LiDAR chip and Shenji NX9031 smart driving chip. This initiative has led to substantial cost savings per vehicle and improved performance, validating Nio's strategy of investing in R&D for higher long-term gross margins. The company aims to standardize automotive chips and expects 35-40% of its automotive semiconductors to be domestically sourced by 2027. | Bullish | 2026-03-19 22:23:01 |
| BMY | Bristol-Myers Squibb (BMS) stock is under investor scrutiny as new clinical trial successes for mezigdomide and FDA approval for Sotyktu are pitted against significant patent cliffs and declining legacy drug revenues. The company's strategic shift toward targeted therapies and immunology is crucial for navigating U.S. biotech patent transitions. Investors, particularly in German-speaking regions, are balancing the high dividend yield and pipeline potential against concerns about revenue forecasts, debt levels, and execution risks ahead of Q1 2026 earnings. | Bearish | 2026-03-19 22:23:01 |
| QQQ | The Invesco QQQ ETF (NASDAQ: QQQ) tracks the Nasdaq-100 Index, offering exposure to the 100 largest non-financial companies on the Nasdaq, including tech giants like Apple and Amazon. It is known for its focus on innovation and technology, high liquidity, and a low annual expense ratio of 0.20%. The article provides a summary, key features, and performance data for the ETF. | Bearish | 2026-03-19 22:23:01 |
| REET | This article compares two global real estate ETFs, Vanguard Global ex-U.S. Real Estate ETF (VNQI) and iShares Global REIT ETF (REET), to help investors choose the best fit. VNQI offers a higher dividend yield and broader international diversification but comes with increased volatility, while REET focuses more on U.S.-listed real estate names. The choice depends on an investor's preference for income vs. growth, regional diversification, and comfort with risk. | Bearish | 2026-03-19 22:23:01 |
| RILYN | B. Riley has increased its price target for Hyperfine, Inc. (NASDAQ: HYPR) to $1.60 from $1.30, while maintaining a Buy rating on the stock. This adjustment follows recent company news, including Hyperfine's Q4 2025 earnings call and a new loan and security agreement. Hyperfine, a health technology company, develops and markets the portable Swoop Portable Magnetic Resonance Imaging System. | Bullish | 2026-03-19 22:23:01 |